The group’s principal activities include developing a portfolio of patented and proprietary technologies that support multiple products in the prescription drug, medical device and OTC products categories. In the year 2006, the group’s patents at merger with Valley Pharmaceuticals, Inc. The group operates from the United States. In the year 2006, the group’s total revenue was $1,368.
